PEPGEN INC. (PEPG) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
9/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LosePEPG / S&P 1.69% / 15.20% |
LosePEPG / S&P PEPG unavailable / 15.00% |
LosePEPG / S&P -65.54% / 50.40% |
| 2026-Q10/3 |
LosePEPG / S&P -72.81% / -4.33% |
LosePEPG / S&P PEPG unavailable / 11.30% |
LosePEPG / S&P -53.35% / 27.70% |
| 2025-Q41/3 |
WinPEPG / S&P 40.91% / 2.65% |
LosePEPG / S&P PEPG unavailable / 9.00% |
LosePEPG / S&P -25.35% / 13.40% |
| 2025-Q31/3 |
WinPEPG / S&P 316.22% / 8.12% |
LosePEPG / S&P PEPG unavailable / 4.61% |
LosePEPG / S&P -5.05% / 13.45% |
| 2025-Q20/3 |
LosePEPG / S&P -21.00% / 10.94% |
LosePEPG / S&P PEPG unavailable / 4.83% |
LosePEPG / S&P -10.03% / 10.63% |
| 2025-Q10/3 |
LosePEPG / S&P -62.93% / -4.27% |
LosePEPG / S&P PEPG unavailable / 4.98% |
LosePEPG / S&P -3.40% / 10.57% |
| 2024-Q40/3 |
LosePEPG / S&P -55.67% / 2.41% |
LosePEPG / S&P PEPG unavailable / 5.25% |
LosePEPG / S&P -13.94% / 6.15% |
| 2024-Q31/3 |
LosePEPG / S&P -46.43% / 5.89% |
LosePEPG / S&P PEPG unavailable / 5.89% |
WinPEPG / S&P 8.79% / 6.11% |
| 2024-Q22/3 |
WinPEPG / S&P 8.57% / 4.28% |
LosePEPG / S&P PEPG unavailable / 5.38% |
WinPEPG / S&P 29.53% / 5.12% |
| 2024-Q12/3 |
WinPEPG / S&P 116.18% / 10.56% |
LosePEPG / S&P PEPG unavailable / 5.71% |
WinPEPG / S&P 9.83% / 5.59% |
| 2023-Q41/3 |
WinPEPG / S&P 33.86% / 11.69% |
LosePEPG / S&P PEPG unavailable / 6.81% |
LosePEPG / S&P -84.43% / 7.78% |
| 2023-Q30/3 |
LosePEPG / S&P -43.18% / -3.27% |
LosePEPG / S&P PEPG unavailable / 7.52% |
LosePEPG / S&P -90.49% / -5.03% |
| 2023-Q20/3 |
LosePEPG / S&P -26.90% / 8.74% |
LosePEPG / S&P PEPG unavailable / 9.50% |
LosePEPG / S&P -93.13% / -8.57% |
| 2023-Q10/3 |
LosePEPG / S&P -8.53% / 7.50% |
LosePEPG / S&P PEPG unavailable / 10.77% |
LosePEPG / S&P -92.94% / -15.69% |
| 2022-Q41/3 |
WinPEPG / S&P 47.25% / 7.56% |
LosePEPG / S&P PEPG unavailable / 11.88% |
LosePEPG / S&P PEPG unavailable / -17.99% |
| 2022-Q30/3 |
LosePEPG / S&P -8.56% / -4.88% |
LosePEPG / S&P PEPG unavailable / 13.47% |
LosePEPG / S&P PEPG unavailable / -1.41% |
| 2022-Q20/3 |
LosePEPG / S&P PEPG unavailable / -16.10% |
LosePEPG / S&P PEPG unavailable / 13.71% |
LosePEPG / S&P PEPG unavailable / 11.04% |
| 2022-Q10/3 |
LosePEPG / S&P PEPG unavailable / -4.60% |
LosePEPG / S&P PEPG unavailable / 15.97% |
LosePEPG / S&P PEPG unavailable / 42.23% |
| 2021-Q40/3 |
LosePEPG / S&P PEPG unavailable / 11.03% |
LosePEPG / S&P PEPG unavailable / 15.00% |
LosePEPG / S&P PEPG unavailable / 96.40% |
| 2021-Q30/3 |
LosePEPG / S&P PEPG unavailable / 0.58% |
LosePEPG / S&P PEPG unavailable / 10.77% |
LosePEPG / S&P PEPG unavailable / 69.42% |
| 2021-Q20/3 |
LosePEPG / S&P PEPG unavailable / 8.55% |
LosePEPG / S&P PEPG unavailable / 6.58% |
LosePEPG / S&P PEPG unavailable / 51.81% |
| 2021-Q10/3 |
LosePEPG / S&P PEPG unavailable / 6.17% |
LosePEPG / S&P PEPG unavailable / -1.06% |
LosePEPG / S&P PEPG unavailable / 7.39% |
| 2020-Q40/3 |
LosePEPG / S&P PEPG unavailable / 12.15% |
LosePEPG / S&P PEPG unavailable / -3.72% |
LosePEPG / S&P PEPG unavailable / -33.42% |
| 2020-Q30/3 |
LosePEPG / S&P PEPG unavailable / 8.93% |
LosePEPG / S&P PEPG unavailable / -2.04% |
LosePEPG / S&P PEPG unavailable / -27.10% |
| 2020-Q20/3 |
LosePEPG / S&P PEPG unavailable / 20.54% |
LosePEPG / S&P PEPG unavailable / -0.46% |
LosePEPG / S&P PEPG unavailable / -27.11% |
| 2020-Q10/3 |
LosePEPG / S&P PEPG unavailable / -19.60% |
LosePEPG / S&P PEPG unavailable / 3.47% |
LosePEPG / S&P PEPG unavailable / -14.75% |
| 2019-Q40/3 |
LosePEPG / S&P PEPG unavailable / 9.07% |
LosePEPG / S&P PEPG unavailable / 5.36% |
LosePEPG / S&P PEPG unavailable / 2.99% |
| 2019-Q30/3 |
LosePEPG / S&P PEPG unavailable / 1.70% |
LosePEPG / S&P PEPG unavailable / 5.02% |
LosePEPG / S&P PEPG unavailable / 0.21% |
| 2019-Q20/3 |
LosePEPG / S&P PEPG unavailable / 4.30% |
LosePEPG / S&P PEPG unavailable / 6.64% |
LosePEPG / S&P PEPG unavailable / 8.65% |
| 2019-Q10/3 |
LosePEPG / S&P PEPG unavailable / 13.65% |
LosePEPG / S&P PEPG unavailable / 8.12% |
LosePEPG / S&P PEPG unavailable / 14.29% |
| 2018-Q40/3 |
LosePEPG / S&P PEPG unavailable / -13.52% |
LosePEPG / S&P PEPG unavailable / 9.05% |
LosePEPG / S&P PEPG unavailable / 18.23% |
| 2018-Q30/3 |
LosePEPG / S&P PEPG unavailable / 7.71% |
LosePEPG / S&P PEPG unavailable / 10.21% |
LosePEPG / S&P PEPG unavailable / 19.06% |
| 2018-Q20/3 |
LosePEPG / S&P PEPG unavailable / 3.43% |
LosePEPG / S&P PEPG unavailable / 9.03% |
LosePEPG / S&P PEPG unavailable / 14.46% |
| 2018-Q10/3 |
LosePEPG / S&P PEPG unavailable / -0.76% |
LosePEPG / S&P PEPG unavailable / 7.68% |
LosePEPG / S&P PEPG unavailable / 12.46% |
| 2017-Q40/3 |
LosePEPG / S&P PEPG unavailable / 6.64% |
LosePEPG / S&P PEPG unavailable / 7.03% |
LosePEPG / S&P PEPG unavailable / 13.82% |
| 2017-Q30/3 |
LosePEPG / S&P PEPG unavailable / 4.48% |
LosePEPG / S&P PEPG unavailable / 5.68% |
LosePEPG / S&P PEPG unavailable / 17.57% |
| 2017-Q20/3 |
LosePEPG / S&P PEPG unavailable / 3.09% |
LosePEPG / S&P PEPG unavailable / 4.83% |
LosePEPG / S&P PEPG unavailable / 17.74% |
| 2017-Q10/3 |
LosePEPG / S&P PEPG unavailable / 6.07% |
LosePEPG / S&P PEPG unavailable / 3.67% |
LosePEPG / S&P PEPG unavailable / 13.32% |
| 2016-Q40/3 |
LosePEPG / S&P PEPG unavailable / 3.82% |
LosePEPG / S&P PEPG unavailable / 2.09% |
LosePEPG / S&P PEPG unavailable / 7.05% |
| 2016-Q30/3 |
LosePEPG / S&P PEPG unavailable / 3.85% |
LosePEPG / S&P PEPG unavailable / 0.20% |
LosePEPG / S&P PEPG unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PEPG total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 164.66% | 20.78% |
| Annualized return | 164.66% | 20.78% |
5Y · 2022-05-06 to 2026-08-27
| Metric | PEPG total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -76.18% | 83.14% |
| Annualized return | -24.95% | 12.86% |
10Y · 2022-05-06 to 2026-08-27
| Metric | PEPG total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -76.18% | 319.30% |
| Annualized return | -13.37% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |